Scholarlink

<p><i>Elizabethkingia</i> is a family of bacteria present in the environment causing infections that have emerged as a significant clinical concern in the Middle East and North Africa region. Despite sporadic reports and case studies, the epidemiology of Elizabethkingia—encompassing its prevalence, antimicrobial resistance profiles, and clinical outcomes—remains largely anecdotal and fragmented. In this review, we systematically screened and analyzed the published literature to provide a comprehensive assessment of the distribution, antibiotic resistance characteristics, and clinical features of <i>Elizabethkingia</i> infections in different samples across the region. Our analysis consolidates existing evidence to highlight the true burden of <i>Elizabethkingia</i> and the emergence of multidrug-resistant strains. By identifying current gaps in data and standardization, this review aims to inform and engage clinicians, microbiologists, epidemiologists, and public health stakeholders in developing coordinated strategies to monitor, prevent, and manage these infections within a One Health framework.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Elizabethkingia in the MENA region (2000–2024): a review of distribution, antimicrobial resistance, and clinical features

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月21日

查看全文
  • Abdallah Alhaj Sulaiman,
  • Mouayad Zuheir Bakleh,
  • Reem Ali,
  • Mustapha Aouida,
  • Dindial Ramotar

摘要

Elizabethkingia is a family of bacteria present in the environment causing infections that have emerged as a significant clinical concern in the Middle East and North Africa region. Despite sporadic reports and case studies, the epidemiology of Elizabethkingia—encompassing its prevalence, antimicrobial resistance profiles, and clinical outcomes—remains largely anecdotal and fragmented. In this review, we systematically screened and analyzed the published literature to provide a comprehensive assessment of the distribution, antibiotic resistance characteristics, and clinical features of Elizabethkingia infections in different samples across the region. Our analysis consolidates existing evidence to highlight the true burden of Elizabethkingia and the emergence of multidrug-resistant strains. By identifying current gaps in data and standardization, this review aims to inform and engage clinicians, microbiologists, epidemiologists, and public health stakeholders in developing coordinated strategies to monitor, prevent, and manage these infections within a One Health framework.